Renaissance Technologies’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Renaissance Technologies’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-700,100	Closed	-$14M	–	4576
2022 Q3	$14M	Sell	700,100 -293,632	-30%	-$3.87M	0.02%	857
2022 Q2	$6.85M	Buy	993,732 +353,532	+55%	+$2.48M	0.01%	1331
2022 Q1	$5.95M	Buy	640,200 +302,300	+89%	+$3.22M	0.01%	1466
2021 Q4	$4.8M	Buy	337,900 +256,000	+313%	+$4.43M	0.01%	1562
2021 Q3	$1.9M	Buy	+81,900	New	+$1.94M	﹤0.01%	2133

Renaissance Technologies's FMTX Position: Q4 2022 in Review

Renaissance Technologies sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 700,100 shares — an estimated $14M sold.

Renaissance Technologies first reported a position in FMTX in Q3 2021 and held it in 5 quarters. The position peaked at $14M in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Renaissance Technologies reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Renaissance Technologies sold 700,100 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $14M.
Renaissance Technologies first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
Renaissance Technologies's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $14M in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.